Analytical Data
-
基因名
GLO2/Glyoxalase II
- Application
-
别名
GLO2; GLX2; GLXII; HAGH1; Glyoxalase II; Hydroxyacyl Glutathione Hydrolase
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q16775
-
表达区间
Met1~Asp308
-
分子量
41kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Glyoxalase II (GLO2) is a crucial enzyme involved in the detoxification of reactive aldehydes, particularly methylglyoxal, through its role in the glyoxalase system. This system is vital for cellular metabolism and protection against oxidative stress, as it helps to regulate the levels of harmful byproducts generated during glycolysis. Recombinant GLO2 has garnered significant interest in recent years due to its potential applications in biotechnology and medicine. By producing GLO2 in a recombinant form, researchers aim to better understand its enzymatic mechanisms, regulatory pathways, and interactions with other cellular components. Additionally, the study of GLO2 has implications for various pathological conditions, including diabetes, neurodegenerative diseases, and cancer, where elevated levels of reactive aldehydes are observed. The recombinant production of GLO2 allows for high-yield purification and characterization, facilitating detailed biochemical studies that can lead to new therapeutic strategies. Understanding GLO2's structure and function further enhances its potential as a drug target or a biomarker for disease progression. Overall, the investigation of recombinant Glyoxalase II represents a promising area of research that bridges fundamental enzymology with practical medical applications.
